Baydas et al. (2005) found that chronic melatonin administration markedly reduced the hyperhomocysteinemia-induced rise in mitochondrial Bax levels, restoring cytosolic Bax values and inhibiting caspase-9 activation in the hippocampus. Here, CASP9 is linked to hyperhomocysteinemia.